We found that HB-derived exosomal lncRNA NEAT1 induced BMSCs to differentiate into tumor-supporting myofibroblasts by regulating the miR-132/MMP9 axis, which might benefit an innovative therapeutic strategy for the treatment of HB patients. This evidence concerns the gene MMP9 and neoplasm.